The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Open accessAbstract
Recent withdrawals of prescription drugs from clinical use because of unexpected side effects on the heart have highlighted the need for more reliable cardiac safety pharmacology assays. Block of the human Ether-a-go go Related Gene (hERG) ion channel in particular is associated with life-threatening arrhythmias, such as Torsade de Pointes (TdP). Here we investigated human cardiomyocytes derived from pluripotent (embryonic) stem cells (hESC) as a renewable, scalable, and reproducible system on which to base cardiac safety pharmacology assays. Analyses of extracellular field potentials in hESC-derived cardiomyocytes (hESC-CM) and generation of derivative field potential duration (FPD) values showed dose-dependent responses for 12 cardiac and noncardiac drugs. Serum levels in patients of drugs with known effects on QT interval overlapped with prolonged FPD values derived from hESC-CM, as predicted. We thus propose hESC-CM FPD prolongation as a safety criterion for preclinical evaluation of new drugs in development. This is the first study in which dose responses of such a wide range of compounds on hESC-CM have been generated and shown to be predictive of clinical effects. We propose that assays based on hESC-CM could complement or potentially replace some of the preclinical cardiac toxicity screening tests currently used for lead optimization and further development of new drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
REDFERN, W., CARLSSON, L., DAVIS, A., LYNCH, W., MACKENZIE, I., PALETHORPE, S., SIEGL, P., STRANG, I., SULLIVAN, A., & WALLIS, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00846-5 · Cited by 1,532
Mummery, C., Ward-van Oostwaard, D., Doevendans, P., Spijker, R., van den Brink, S., Hassink, R., van der Heyden, M., Opthof, T., Pera, M., de la Riviere, A. B., et al. (2003) · Circulation · doi:10.1161/01.cir.0000068356.38592.68 · Cited by 1,001
Self-citationMultiple Mechanisms in the Long-QT Syndrome: Current Knowledge, Gaps, and Future Directions
Roden, D. M., Lazzara, R., Rosen, M., Schwartz, P. J., Towbin, J., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 628
Stem-cell-based therapy and lessons from the heart
Passier, R., van Laake, L. W., & Mummery, C. L. (2008) · Nature · doi:10.1038/nature07040 · Cited by 525
Self-citationIncreased Cardiomyocyte Differentiation from Human Embryonic Stem Cells in Serum‐Free Cultures
Passier, R., Oostwaard, D. W., Snapper, J., Kloots, J., Hassink, R. J., Kuijk, E., Roelen, B., de la Riviere, A. B., & Mummery, C. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0184 · Cited by 324
Self-citationHERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
Roy, M.-L., Dumaine, R., & Brown, A. M. (1996) · Circulation · doi:10.1161/01.cir.94.4.817 · Cited by 303
Long QT syndrome: from channels to cardiac arrhythmias
Moss, A. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25537 · Cited by 296
Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes
Satin, J., Kehat, I., Caspi, O., Huber, I., Arbel, G., Itzhaki, I., Magyar, J., Schroder, E. A., Perlman, I., & Gepstein, L. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.068213 · Cited by 283
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation
Huber, I., Itzhaki, I., Caspi, O., Arbel, G., Tzukerman, M., Gepstein, A., Habib, M., Yankelson, L., Kehat, I., & Gepstein, L. (2007) · The FASEB Journal · doi:10.1096/fj.05-5711com · Cited by 259
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK
Graichen, R., Xu, X., Braam, S. R., Balakrishnan, T., Norfiza, S., Sieh, S., Soo, S. Y., Tham, S. C., Mummery, C., Colman, A., et al. (2008) · Differentiation · doi:10.1111/j.1432-0436.2007.00236.x · Cited by 245
Self-citationAnti-HERG activity and the risk of drug-induced arrhythmias and sudden death
De Bruin, M. L., Pettersson, M., Meyboom, R. H. B., Hoes, A. W., & Leufkens, H. G. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi092 · Cited by 245
Transgenic Enrichment of Cardiomyocytes From Human Embryonic Stem Cells
Anderson, D., Self, T., Mellor, I. R., Goh, G., Hill, S. J., & Denning, C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300303 · Cited by 231
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Caspi, O., Itzhaki, I., Kehat, I., Gepstein, A., Arbel, G., Huber, I., Satin, J., & Gepstein, L. (2009) · Stem Cells and Development · doi:10.1089/scd.2007.0280 · Cited by 221
QTc interval prolongation and antipsychotic drug treatments: focus on sertindole
Lindström, E., Farde, L., Eberhard, J., & Haverkamp, W. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005250 · Cited by 207
Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes
DARPO, B. (2001) · European Heart Journal Supplements · doi:10.1016/s1520-765x(01)90009-4 · Cited by 205
Martin, R. L., McDermott, J. S., Salmen, H. J., Palmatier, J., Cox, B. F., & Gintant, G. A. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200403000-00007 · Cited by 178
Drolet, B., Rousseau, G., Daleau, P., Cardinal, R., & Turgeon, J. (2000) · Circulation · doi:10.1161/01.cir.102.16.1883 · Cited by 165
Freund, C. M. A. H., Oostwaard, D. W., Monshouwer‐Kloots, J., van den Brink, S., van Rooijen, M. A., Xu, X., Zweigerdt, R., Mummery, C. L., & Passier, R. C. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0617 · Cited by 153
Self-citationThe hESC line Envy expresses high levels of GFP in all differentiated progeny
Costa, M., Dottori, M., Ng, E., Hawes, S. M., Sourris, K., Jamshidi, P., Pera, M. F., Elefanty, A. G., & Stanley, E. G. (2005) · Nature Methods · doi:10.1038/nmeth748 · Cited by 131
Highly enriched cardiomyocytes from human embryonic stem cells
Xu, X. Q., Zweigerdt, R., Soo, S. Y., Ngoh, Z. X., Tham, S. C., Wang, S. T., Graichen, R., Davidson, B. P., Colman, A., & Sun, W. Y. (2008) · Cytotherapy · doi:10.1080/14653240802105307 · Cited by 113
Cavero, I., & Crumb, W. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.3.509 · Cited by 91
Patterning the heart, a template for human cardiomyocyte development
Lopes, S. M. C. D. S., Hassink, R. J., Feijen, A., van Rooijen, M. A., Doevendans, P. A., Tertoolen, L. G. J., de la Rivière, A. B., & Mummery, C. L. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20830 · Cited by 71
Self-citationMummery, C. L., Ward, D., & Passier, R. C. (2007) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc01f02s2 · Cited by 68
Self-citationThe electrocardiogram of human embryonic stem cell–derived cardiomyocytes
Reppel, M., Pillekamp, F., Brockmeier, K., Matzkies, M., Bekcioglu, A., Lipke, T., Nguemo, F., Bonnemeier, H., & Hescheler, J. (2005) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2005.06.029 · Cited by 64
CARDIOTOXICITY OF INTRAVENOUS DOMPERIDONE
Osborne, R. J., Slevin, M. L., Hunter, R. W., & Hamer, J. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92515-2 · Cited by 60
Human embryonic stem cells: Genetic manipulation on the way to cardiac cell therapies
Moore, J. C., Laake, L. W. V., Braam, S. R., Xue, T., Tsang, S. Y., Ward, D., Passier, R. C., Tertoolen, L. G. J., Li, R. A., & Mummery, C. L. (2005) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.04.012 · Cited by 57
Self-citationCardiomyocyte differentiation from embryonic and adult stem cells
Passier, R. C., & Mummery, C. L. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.08.003 · Cited by 51
Self-citationInhibition of L-Type Ca2+Channel Current in Rat Ventricular Myocytes by Terfenadine
Liu, S., Melchert, R. B., & Kennedy, R. H. (1997) · Circulation Research · doi:10.1161/01.res.81.2.202 · Cited by 49
Terrar, D. A., Wilson, C. M., Graham, S., Bryant, S. M., & Heath, B. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.04.005 · Cited by 41
Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity
Denning, C. N., & Anderson, D. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.08.002 · Cited by 36
Quinidine Interactions With Human Atrial Potassium Channels
Nenov, N. I., Crumb, W., Pigott, J. D., Harrison, L. H., & Clarkson, C. W. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1224 · Cited by 29
Effect of verapamil on QT interval dynamicity
Fauchier, L., Babuty, D., Poret, P., Autret, M. L., Cosnay, P., & Fauchier, J. P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01001-7 · Cited by 24
ICH Expert Working Group Topic Leaders:, Bode, G., & Olejniczak, K. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00079.x · Cited by 18
Cited by
Mummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.227512 · Cited by 713
Self-citationBurridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
Fishman, G. I., Chugh, S. S., DiMarco, J. P., Albert, C. M., Anderson, M. E., Bonow, R. O., Buxton, A. E., Chen, P.-S., Estes, M., Jouven, X., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.976092 · Cited by 614
Liang, P., Lan, F., Lee, A. S., Gong, T., Sanchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 537
Lewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25329-5 · Cited by 536
Metadata
- Authors
- Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L.
- Venue
- Stem Cell Research
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 4
- Issue
- 2
- Pages
- 107-116
- ISSN
- 1873-5061 (ISSN-L)
- OpenAlex
- W2031383358
- Cited by
- 368
- References
- 34
- FWCI
- 17.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.